Companies / CU6

CLARITY PHARMACEUTICALS LTD

ASX:CU6Pharmaceuticals, Biotechnology & Life Sciences
373.1M shares on issueASX (delayed) · as of 28 July 2026$2.23price · delayed$876.7Mmarket cap · indicative
C
Dilution grade

Share count grew 20% in 24 months; runway 4–8 quarters; 2 cash raises in 24 months

Cash runway6.8 quarters of funding
Share-count growth (24m)19.7%
Raise cadence (24m)2 cash raises
Options & rights overhang10.5% of shares
In-the-money supply4.0% of shares
Pending proposed issuesnone

CLARITY PHARMACEUTICALS LTD's ordinary share count grew 19.7% between June 2024 and July 2026 to 373M shares. The company raised capital twice in the 24-month window for total proceeds of A$407.3M, most recently a A$203.6M placement in July 2025. Options and rights could convert into 39M new shares, equal to 10.5% of the current share count, of which 4% are in the money at the current share price; the nearest expiry is May 2027. At the March 2026 quarter the company reported A$173.8M in cash, covering 6.8 quarters at recent spending levels. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
10.5%
Max option dilution
4.0%
ITM option dilution
1
Raises · last 12 months
6.8 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 373.1M per ASX (delayed) (28 July 2026).
331.3M346.6M362.0MDec 24Sept 25July 26Cash raise · 28 July 2025Cash raise · 25 July 2025

Cash runway

6.8 qtrs
More than four quarters of funding at the recent spend rate.
$173.8M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
1 July 20262A · quoted issueCU6 : ORDINARY FULLY PAID373.1MAppendix 2A
27 May 20263G · unquotedORDINARY FULLY PAID373.0MAppendix 3G
20 May 20262A · quoted issueCU6 : ORDINARY FULLY PAID373.0MAppendix 2A
7 Apr 20263G · unquotedORDINARY FULLY PAID372.3MAppendix 3G
31 Mar 20262A · quoted issueCU6 : ORDINARY FULLY PAID372.3MAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

2 cash raises in the last 24 months · 1 in the last 12 months

$203.6M
Placement
28 July 2025 COMPLETE
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

10.5%
Total overhang · of current shares
4.0%
In the money · at current price
39.2M
Potential new shares
May 2027
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
20 Apr 2026Michelle ParkerSell———3Y notice
25 Nov 2025Colin David BigginOther—487k$788k3Y notice
25 Nov 2025Michelle ParkerOther—512k$827k3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

16 July 2026Initial Director's Interest Notice - Rossiter
15 July 2026Allison Rossiter joins Clarity Board of Directors
7 July 2026Ceasing to be a substantial holder
6 July 2026Ceasing to be a substantial holder
1 July 2026Cleansing Notice
1 July 2026Application for quotation of securities - CU6
30 June 2026Becoming a substantial holder
28 June 2026$PData on SAR-bisPSMA to be presented at EANM
25 June 2026Clarity celebrates 100-employee milestone
25 June 2026Ceasing to be a substantial holder
22 June 2026Ceasing to be a substantial holder
18 June 2026Change in substantial holding
17 June 2026Becoming a substantial holder
27 May 2026Notification regarding unquoted securities - CU6
20 May 2026Cleansing Notice
20 May 2026Application for quotation of securities - CU6
13 May 2026$PClarity receives $9.8 million R&D tax incentive refund
30 Apr 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
22 Apr 2026Change of Director's Interest Notice - Parker
13 Apr 2026$PClarity signs a Commercial Manufacturing Agreement

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.